Constructed wetlands are increasingly proposed as nature-based solutions for decentralized wastewater treatment and agricultural water reuse; however, integrated evaluations of contaminant removal and associated environmental and human health risks across enhanced wetland configurations remain limited. This study evaluated twelve target analytical parameters representing pharmaceuticals and industrial micropollutants in six pilot-scale treatment configurations assembled from horizontal-flow and vertical-flow wetland units operated under aerated and non-aerated conditions. The aerated vertical-flow followed by the aerated horizontal-flow configuration achieved the highest removal for several compounds, including clarithromycin (70.6%), benzotriazole (69.8%), diclofenac (62.2%), venlafaxine (61.2%), and metoprolol (47.6%), whereas carbamazepine and sartans remained poorly removed (<15.0%). Screening-level environmental risk assessment identified diclofenac, clarithromycin, and citalopram as the principal ecological risk drivers, with risk quotients remaining above 1.0 after treatment in several configurations. In contrast, the modelled lettuce-irrigation assessment yielded individual hazard quotients below 0.1. The combined analysis therefore revealed a key risk-management contrast: configurations that improved contaminant attenuation reduced both cumulative risk metrics, but ecological concern could persist even when modelled human health risk remained low.

Khoshbin, S., Mancuso, G., Testaquatra, G., Drei, P., Annesi, G., Lavrnić, S., et al. (2026). Treatment of contaminants of emerging concern by constructed wetlands: removal and risk assessment under discharge and agricultural irrigation scenarios. WATER RESEARCH. X, 33, 1-13 [10.1016/j.wroa.2026.100632].

Treatment of contaminants of emerging concern by constructed wetlands: removal and risk assessment under discharge and agricultural irrigation scenarios

Khoshbin, Samira;Mancuso, Giuseppe
;
Testaquatra, Gabriele;Drei, Pietro;Annesi, Gianvito;Lavrnić, Stevo;Toscano, Attilio
2026

Abstract

Constructed wetlands are increasingly proposed as nature-based solutions for decentralized wastewater treatment and agricultural water reuse; however, integrated evaluations of contaminant removal and associated environmental and human health risks across enhanced wetland configurations remain limited. This study evaluated twelve target analytical parameters representing pharmaceuticals and industrial micropollutants in six pilot-scale treatment configurations assembled from horizontal-flow and vertical-flow wetland units operated under aerated and non-aerated conditions. The aerated vertical-flow followed by the aerated horizontal-flow configuration achieved the highest removal for several compounds, including clarithromycin (70.6%), benzotriazole (69.8%), diclofenac (62.2%), venlafaxine (61.2%), and metoprolol (47.6%), whereas carbamazepine and sartans remained poorly removed (<15.0%). Screening-level environmental risk assessment identified diclofenac, clarithromycin, and citalopram as the principal ecological risk drivers, with risk quotients remaining above 1.0 after treatment in several configurations. In contrast, the modelled lettuce-irrigation assessment yielded individual hazard quotients below 0.1. The combined analysis therefore revealed a key risk-management contrast: configurations that improved contaminant attenuation reduced both cumulative risk metrics, but ecological concern could persist even when modelled human health risk remained low.
2026
Khoshbin, S., Mancuso, G., Testaquatra, G., Drei, P., Annesi, G., Lavrnić, S., et al. (2026). Treatment of contaminants of emerging concern by constructed wetlands: removal and risk assessment under discharge and agricultural irrigation scenarios. WATER RESEARCH. X, 33, 1-13 [10.1016/j.wroa.2026.100632].
Khoshbin, Samira; Mancuso, Giuseppe; Testaquatra, Gabriele; Drei, Pietro; Annesi, Gianvito; Lavrnić, Stevo; Toscano, Attilio
File in questo prodotto:
File Dimensione Formato  
2026_Treatment of contaminants of emerging concern.pdf

accesso aperto

Tipo: Versione (PDF) editoriale / Version Of Record
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Non opere derivate (CCBYNCND)
Dimensione 4.76 MB
Formato Adobe PDF
4.76 MB Adobe PDF Visualizza/Apri
1-s2.0-S2589914726001593-mmc1.docx

accesso aperto

Tipo: File Supplementare
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Non opere derivate (CCBYNCND)
Dimensione 996.99 kB
Formato Microsoft Word XML
996.99 kB Microsoft Word XML Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/1092472
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex ND
social impact